N-myristoylation of a peptide substrate for Src converts it into an apparent slow-binding bisubstrate-type inhibitor
- 1 May 1999
- journal article
- research article
- Published by Wiley in Chemical Biology & Drug Design
- Vol. 53 (5) , 569-577
- https://doi.org/10.1034/j.1399-3011.1999.00063.x
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Discovery of a Novel Series of Potent and Selective Substrate-Based Inhibitors of p60c-src Protein Tyrosine Kinase: Conformational and Topographical Constraints in Peptide DesignJournal of Medicinal Chemistry, 1998
- Structures of Src-family tyrosine kinasesCurrent Opinion in Structural Biology, 1997
- Three-dimensional structure of the tyrosine kinase c-SrcNature, 1997
- A Synthetic Peptidic Substrate of Minimal Size and Semi-optimal Sequence for the Protein Tyrosine Kinase pp60c-srcArchives of Biochemistry and Biophysics, 1996
- Src and the control of cell divisionBioEssays, 1996
- SH2 and SH3 domains: Potential targets for anti-cancer drug designJournal of Pharmacological and Toxicological Methods, 1995
- Identification of efficient pentapeptide substrates for the tyrosine kinase pp60c-srcJournal of Medicinal Chemistry, 1995
- Patent Update: Oncologic, Endocrine & Metabolic Small molecule inhibitors of tyrosine kinase activityExpert Opinion on Therapeutic Patents, 1995
- Potentiation of epidermal growth factor receptor-mediated oncogenesis by c-Src: implications for the etiology of multiple human cancers.Proceedings of the National Academy of Sciences, 1995
- Identification and characterization of a novel synthetic peptide substrate specific for Src‐family protein tyrosine kinasesInternational Journal of Peptide and Protein Research, 1995